Conimune ME 50mg capsule contains the active ingredient cyclosporine. It is a medication that belongs to a class of drugs known as immunosuppressants. It is primarily used to prevent organ rejection in patients who have undergone organ transplantation, such as kidney, liver, or heart transplants. It is used with other medicines to prevent the rejection of the new organ by the body’s immune system. After solid organ transplantation, the body generates an aggressive immune response because it recognizes the transplanted organ’s antigens as foreign antigens. Thus, treatment with immunosuppressive agents is necessary after an organ transplant to prevent organ rejection.
Immunosuppressants increase the risk of skin cancer. Limit your exposure to the sun, wear protective clothing, and use sunscreen with high SPF. Inform your physician if you have recently taken vaccination with live vaccines. It should not be used in individuals with known hypersensitivity or allergy to conimune ME 50mg capsule or its components. This medication can raise blood pressure levels. It should be used cautiously or avoided in individuals with uncontrolled high blood pressure or a history of hypertension. Discussing potential reproductive effects with a healthcare professional, especially for individuals planning to conceive, is important. Diabetes monitoring is important, especially for individuals at risk.
Conimune ME 50 Capsule is utilized to prevent organ rejection and to manage psoriasis and rheumatoid arthritis. The specific applications of Conimune ME 50 Capsule are detailed below:
Management of Organ Transplant Rejection: Conimune ME 50 Capsule is employed to prevent organ transplant rejection following liver, kidney, pancreas, lung, heart, skin, and bone marrow transplants.
Management of Psoriasis: Conimune ME 50 Capsule is indicated for the treatment of psoriasis. It aids in diminishing rapid skin cell proliferation and inflammation associated with psoriasis.
Management of Rheumatoid Arthritis: Conimune ME 50 Capsule is prescribed for the treatment of rheumatoid arthritis. It assists in alleviating pain and inflammation in the joints and helps to slow the progression of joint damage.
Conimune ME 50mg capsule aids in preventing organ rejection in transplant recipients by suppressing the immune system. Following an organ transplant, the immune system identifies the new organ as foreign and initiates an immune response to attack and reject it. The capsule works by inhibiting the activation of T-cells, which are a type of white blood cell that plays a crucial role in immune responses. By suppressing T-cell activity, Conimune ME 50mg capsule helps to protect the transplanted organ from being attacked and damaged by the immune system, thus enhancing the likelihood of a successful organ transplant.
Notify your healthcare provider of all the medications you are currently taking, which includes prescription drugs, over-the-counter medications, nutritional and vitamin supplements, as well as herbal products.
Some medications may interact with conimune ME 50mg capsule, diminishing its effectiveness and leading to unwanted side effects.
Conimune ME 50 Capsule can be taken with or without food.
It is usually taken 2 times a day or as prescribed by your doctor.
Swallow Conimune ME 50 Capsule as a whole with a glass of water.
Do not crush, chew, or open it.
• Store in a cool and dry place away from sunlight.
• Keep Conimune ME 50 Capsule out of the sight and reach of children.
• Non cold chain - To be stored in cool places at 10ºC to 25ºC or below 30ºC.
Serious
Kidney damage
Liver damage
Infection, fever or sore throat
Lack of coordination
Memory problems
Difficulty in speaking
Visual problems
Seizures
Confusion
Personality changes
Sleeplessness
Agitation
Common
Hypertension
Electrolyte imbalance
Increased level of potassium in the blood
Tremor
Abnormal hair growth
Enlargement of gum tissues
Low levels of magnesium
Risk of infections
Headache
Gastrointestinal disturbances
Do not use Conimune ME 50 Capsule if you are allergic to any of its ingredients.
Before using Conimune ME 50 Capsule, inform your doctor if you have or have had liver or kidney issues, epilepsy, hypertension, low magnesium levels, high potassium levels, cancer, or any infections.
Conimune ME 50 Capsule may increase your risk of infections; seek medical advice if you experience any severe symptoms such as fever, sore throat, difficulty breathing, jaundice, unexplained bleeding, or bruising.
Prior to taking Conimune ME 50 Capsule, notify your doctor if you have any form of cancer.
Consult your healthcare provider before using Conimune ME 50 Capsule if you are pregnant or planning to become pregnant.
Breastfeeding mothers should avoid taking Conimune ME 50 Capsule as it can be transferred to breast milk.
Make sure to inform your doctor about your medical history and any medications you are taking to prevent any adverse side effects.
Fact Box of CONIMUNE ME 50MG
Molecule Name: Cyclosporine
Therapeutic Class: Immunosuppressants
Pharmacological Class: Immunosuppressant agents
Indications:
1. Prevention of organ rejection (Kidney, liver, and heart)
2. Treatment of Rheumatoid Arthritis and Psoriasis
Disclaimer
At Medfast, we’re dedicated to bringing you accurate, trustworthy, and expert-vetted health information. Our primary goal is to ensure you receive content that you can rely on.
It’s crucial to understand that everything on this website is for general information purposes only. This content is not a substitute for professional medical advice, diagnosis, or treatment. We can’t stress enough the importance of consulting with your own doctor. They are the only ones who can provide tailored advice for your specific health concerns or medication questions.
Please, never ignore or delay seeking professional medical advice because of something you’ve read here. Our fundamental mission is to support and enhance the doctor-patient relationship, not to replace it.
